Category: Info Sheet
Purpose-Built for ADC Development Antibody-drug conjugates (ADCs) are transforming cancer care by combining precision antibody targeting with potent payloads Read Now
Specialized Site Network for Early-phase Oncology Success Early-phase oncology trials are complex, demanding precision, rapid execution, and specialized expertise. Read Now
Advancing Lung Cancer Trials with Precision Lung cancer is the second most diagnosed cancer and the leading cause of cancer-related deaths Read Now
Developing Cutting-edge Treatments for Ovarian Cancer Ovarian cancer is the second most common gynecological cancer worldwide and carries the highest mortality Read Now
Early-Phase Oncology Research Expertise Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now
Driving Innovation in Radiopharmaceutical Therapies Oncology clinical research is complex, demanding, and continually evolving. Bringing effective radiopharmaceutical therapies from proof-of-concept Read Now
Developing Next-generation Therapies for Breast Cancer Patients Breast cancer is the second most common malignancy worldwide and the number one cancer in Read Now
Helping to Develop Cell Therapies Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now
Helping to Bring Antibody Drug Conjugates (ADCs) to Patients Catalyst Oncology is a specialty oncology contract research organization (CRO) devoting time, energy, and capital Read Now